# Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer

> **NCT02595554** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 220 (estimated)

## Conditions studied

- Cervical Carcinoma Stage IIB

## Interventions

- **RADIATION:** Concurrent chemoirradiation
- **DRUG:** Paclitaxel
- **PROCEDURE:** Radical Surgery
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02595554
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2017-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595554, "Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02595554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*